Inovio Pharmaceuticals
INO
#8848
Rank
HK$1.16 B
Marketcap
HK$16.92
Share price
-3.33%
Change (1 day)
21.59%
Change (1 year)

EPS for Inovio Pharmaceuticals (INO)

EPS in 2025 (TTM): -HK$22.45

According to Inovio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -HK$22.40. In 2024 the company made an earnings per share (EPS) of -HK$30.72 an increase over its 2023 EPS that were of -HK$47.37.

EPS history for Inovio Pharmaceuticals from 1999 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$22.45-26.95%
2024-HK$30.72-35.14%
2023-HK$47.37-56.62%
2022-HK$109.21-19.54%
2021-HK$135.7335.9%
2020-HK$99.87-11.57%
2019-HK$112.9415.24%
2018-HK$98.01-2.78%
2017-HK$100.816.93%
2016-HK$94.27134.88%
2015-HK$40.14-29.51%
2014-HK$56.94-57.34%
2013-HK$133.47146.55%
2012-HK$54.1420.83%
2011-HK$44.80-29.41%
2010-HK$63.47-48.48%
2009-HK$123.2110%
2008-HK$112.0111.11%
2007-HK$100.81-41.3%
2006-HK$171.74-66.91%
2005-HK$518.96110.61%
2004-HK$246.41-61.63%
2003-HK$642.17186.67%
2002-HK$224.01
2001N/A-100%
2000-HK$179.21-63.64%
1999-HK$492.83

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
HK$13.38-159.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$81.20-462.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
-HK$9.72-56.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$57.25-355.56%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
HK$59.07-363.67%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
HK$27.97-224.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
Gilead Sciences
GILD
HK$50.71-326.39%๐Ÿ‡บ๐Ÿ‡ธ USA